Wolverine Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.85M | Buy |
+114,700
| New | +$8.96M | 0.01% | 1001 |
|
|
2025
Q2 | – | Sell |
-105,300
| Closed | -$7.47M | – | 4981 |
|
|
2025
Q1 | $7.47M | Sell |
105,300
-59,700
| -36% | -$4.27M | 0.01% | 773 |
|
|
2024
Q4 | $12.2M | Sell |
165,000
-135,200
| -45% | -$9.46M | 0.01% | 688 |
|
|
2024
Q3 | $20M | Buy |
300,200
+218,900
| +269% | +$15.9M | 0.02% | 439 |
|
|
2024
Q2 | $7.51M | Sell |
81,300
-11,400
| -12% | -$1.01M | 0.01% | 764 |
|
|
2024
Q1 | $8.86M | Sell |
92,700
-43,100
| -32% | -$3.62M | 0.01% | 701 |
|
|
2023
Q4 | $10.4M | Buy |
135,800
+25,700
| +23% | +$1.79M | 0.01% | 707 |
|
|
2023
Q3 | $7.63M | Buy |
110,100
+26,100
| +31% | +$2.1M | 0.01% | 756 |
|
|
2023
Q2 | $7.73M | Buy |
84,000
+41,500
| +98% | +$3.61M | 0.01% | 693 |
|
|
2023
Q1 | $3.47M | Sell |
42,500
-12,300
| -22% | -$967K | 0.01% | 1031 |
|
|
2022
Q4 | $4.09M | Buy |
54,800
+15,000
| +38% | +$1.16M | 0.01% | 999 |
|
|
2022
Q3 | $3.34M | Sell |
39,800
-3,700
| -9% | -$356K | 0.01% | 1073 |
|
|
2022
Q2 | $4.18M | Sell |
43,500
-3,700
| -8% | -$383K | 0.01% | 888 |
|
|
2022
Q1 | $5.53M | Buy |
+47,200
| New | +$5.3M | 0.01% | 1016 |
|
|
2021
Q4 | – | Sell |
-65,200
| Closed | -$7.4M | – | 6148 |
|
|
2021
Q3 | $7.4M | Buy |
+65,200
| New | +$7.44M | 0.01% | 1012 |
|
|
2021
Q2 | – | Sell |
-27,300
| Closed | -$2.26M | – | 6199 |
|
|
2021
Q1 | $2.26M | Buy |
+27,300
| New | +$2.31M | ﹤0.01% | 1827 |
|
|
2020
Q4 | – | Sell |
-84,300
| Closed | -$6.6M | – | 4968 |
|
|
2020
Q3 | $6.6M | Buy |
+84,300
| New | +$6.58M | 0.02% | 712 |
|
|
2020
Q2 | – | Sell |
-85,500
| Closed | -$5.59M | – | 4736 |
|
|
2020
Q1 | $5.59M | Sell |
85,500
-84,000
| -50% | -$6.06M | 0.02% | 707 |
|
|
2019
Q4 | $13.1M | Sell |
169,500
-13,500
| -7% | -$1.05M | 0.03% | 548 |
|
|
2019
Q3 | $13.3M | Buy |
+183,000
| New | +$12.9M | 0.04% | 411 |
|
|
2019
Q2 | – | Sell |
-342,600
| Closed | -$21.9M | – | 4600 |
|
|
2019
Q1 | $21.9M | Buy |
342,600
+172,200
| +101% | +$9.83M | 0.06% | 234 |
|
|
2018
Q4 | $8.54M | Buy |
170,400
+26,700
| +19% | +$1.35M | 0.02% | 537 |
|
|
2018
Q3 | $8.34M | Buy |
143,700
+31,500
| +28% | +$1.54M | 0.02% | 647 |
|
|
2018
Q2 | $5.22M | Hold |
112,200
| – | – | 0.01% | 842 |
|
|
2018
Q1 | $5.22M | Buy |
+112,200
| New | +$4.87M | 0.01% | 842 |
|
|
2017
Q3 | – | Sell |
-162,300
| Closed | -$6.34M | – | 4573 |
|
|
2017
Q2 | $6.34M | Buy |
162,300
+95,400
| +143% | +$3.48M | 0.03% | 560 |
|
|
2017
Q1 | $2.09M | Sell |
66,900
-66,900
| -50% | -$2.09M | 0.01% | 1155 |
|
|
2016
Q4 | $4.18M | Buy |
+133,800
| New | +$4.34M | 0.02% | 838 |
|
Other funds holding EW
Wolverine Trading's EW Position: Q4 2024 in Review
Wolverine Trading sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 26,266 shares — an estimated $1.84M sold.
Wolverine Trading first reported a position in EW in Q4 2016 and held it in 15 quarters. The position peaked at $3.74M in Q4 2019. 1,226 funds tracked by Wall St. Rank hold EW as of Q4 2024.
- Wolverine Trading reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
- Wolverine Trading sold 26,266 Edwards Lifesciences shares in Q4 2024, an estimated $1.84M.
- Wolverine Trading first reported a position in Edwards Lifesciences in Q4 2016 and held it in 15 quarters.
- Wolverine Trading's Edwards Lifesciences position peaked at $3.74M in Q4 2019.
- 1,226 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.
Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.